Principal Investigator:
Jeffrey Greenberg, MD, MPH
Dr. Greenberg and his laboratory are working on the identification of genetic and other biomarkers that can predict whether or not an individual patient will respond or experience a serious adverse event.
Specifically, the team’s research is currently focused on identifying prognostic genetic biomarkers for rheumatoid arthritis patients treated with biologic agents.
Other ongoing projects include research collaborations with multiple industry partners to identify leukocyte gene expression profiles of arthritic disease susceptibility, response to biologic agents and disease progression.
This page contains a listing of articles authored or co-authored by Dr. Jeffrey Greenberg.
(This list may take a moment to appear.)
|
Loading Publications...
|